Showing results (511-520 of 2,206) with videos related to
Sort By:
Pageof 221
Biological Psychiatry|August 1, 1976
Urinary excretion of 3-methoxy-4-hydroxyphenylglycol in depressed patients: modifications by amphetamine and lithiumH Beckmann, D P van Kammen, F K Goodwin, et al.Schizophrenia Bulletin|January 1, 1980
Parents of high risk subjects defined by levels of monoamine oxidase activityL B Puchall, R D Coursey, M S Buchsbaum, et al.Archives of General Psychiatry|October 1, 1985
Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacyA Zametkin, J L Rapoport, D L Murphy, et al.Life Sciences|August 10, 1987
M-chlorophenylpiperazine increases blood pressure and heart rate in pithed and conscious ratsG Bagdy, K Szemeredi, Z Zukowska-Grojec, et al.Psychopharmacology|January 1, 1988
Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgylineC S Aulakh, J L Hill, K M Wozniak, et al.Biological Psychiatry|September 7, 2001
Motor cortex excitability correlates with an anxiety-related personality traitE M Wassermann, B D Greenberg, M B Nguyen, et al.Pharmacology, Biochemistry, and Behavior|May 1, 1989
Differential effect of clomipramine treatment on m-chlorophenylpiperazine-induced increases in plasma prolactin and corticosterone in ratsK M Wozniak, C S Aulakh, J L Hill, et al.American Journal of Hematology|September 1, 1986
Erythrocyte Rh antigens increase with red cell ageS K Ballas, J C Flynn, L A Pauline, et al.Clinical Pharmacology and Therapeutics|August 1, 1982
Plasma steady-state concentrations of hydroxylated metabolites of clomipramineM Linnoila, T Insel, C Kilts, et al.Journal of Clinical Psychopharmacology|March 1, 1981
Use of dexamethasone suppression test in clinical psychiatryN H Kalin, S C Risch, D S Janowsky, et al.Pageof 221